The emerging therapy of this peptide represents a significant development in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – leading https://tirzepatidepeptide120692.aioblogs.com/94804406/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment